A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting

Completed

Conditions studied: Gram-Positive Bacterial Infections

In brief

This study is a retrospective, observational study to evaluate oritavancin use in participants under real world conditions.

Key facts

Study ID

NCT03159403

Run by

Melinta Therapeutics, Inc.

People needed

325

Starts

2017-04-12

Expected to finish

2018-03-08

Last updated by the study team

2018-03-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participant was treated with at least one dose of oritavancin for a suspected or confirmed gram positive infection, as monotherapy or part of a broader regimen.
• At least 60 days has elapsed since the participant received the last dose of oritavancin therapy (prior to data entry into the electronic Case Report Form).

You may not qualify if…

• The participant received oritavancin as a part of a controlled clinical trial.
• The participant received oritavancin as a part of a Medicines Company-sponsored single or multi-centered pharmacoeconomic outcomes study.

Where it is running

• Birmingham Infectious Disease and Infusion — Birmingham, Alabama, United States
• Santa Barbara Cottage Hospital — Santa Barbara, California, United States
• Florida Infectious Disease Care — Fort Myers, Florida, United States
• Infectious Diseases Associates of North Central Florida, LLC — Ocala, Florida, United States
• WellStar Health System - Kennestone — Marietta, Georgia, United States
• Snake River Research, PLLC — Idaho Falls, Idaho, United States
• St. Vincent Hospital and Health Care Center, Inc. — Indianapolis, Indiana, United States
• Methodist Jennie Edmundson Hospital — Council Bluffs, Iowa, United States
• IDC Clinical Research, LLC — Wichita, Kansas, United States
• Clinical Infectious Disease Specialists — Las Vegas, Nevada, United States
• New York-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York, United States
• Erie County Medical Center — Buffalo, New York, United States
• Trinity Health Medical Group — Minot, North Dakota, United States
• Infectious Diseases Consultants of OKC — Oklahoma City, Oklahoma, United States
• TruCare Internal Medicine and Infectious Diseases — DuBois, Pennsylvania, United States
• Allegheny General Hospital — Pittsburgh, Pennsylvania, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• Center for Infectious Diseases & Travel Medicine — El Paso, Texas, United States
• Houston Center For Infectious Diseases — The Woodlands, Texas, United States
• Infectious Disease and Pulmonary — Victoria, Texas, United States
• Foot & Ankle Institute — St. George, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.